Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
33%(2 trials)

Phase Distribution

Ph phase_4
2
29%
Ph phase_3
2
29%
Ph not_applicable
1
14%
Ph phase_1
1
14%

Phase Distribution

1

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(6)
Terminated(1)

Detailed Status

Completed6
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 32 (33.3%)
Phase 42 (33.3%)
N/A1 (16.7%)

Trials by Status

withdrawn114%
completed686%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_3

A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma

NCT01202097
completed

Replication of the INSPIRE Trial in Healthcare Claims Data

NCT05179512
completedphase_3

Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma

NCT02571777
completedphase_4

Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD

NCT02603393
completedphase_1

Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)

NCT03238482
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT01202097Phase 3

A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma

Completed
NCT05179512

Replication of the INSPIRE Trial in Healthcare Claims Data

Completed
NCT02571777Phase 3

Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma

Completed
NCT02603393Phase 4

Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD

Completed
NCT03238482Phase 1

Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)

Completed
NCT00315744Phase 4

Viapaed Study In Children And Adolescents With Asthma

Completed
NCT00741767Not Applicable

The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD

Withdrawn

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7